Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
-
+
EP08.01-018 - Patterns of Failure in Metastatic NSCLC Treated with First Line Pembrolizumab and Impact of Local Therapy in Patients with Oligoprogression
Presenter: Cole Friedes- Abstract
Loading...
-
+
P1.10 - Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
- 17:00 - 19:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
-
+
P1.10-01 - Phase 3 Study of Durvalumab Combined with Oleclumab or Monalizumab in Patients with Unresectable Stage III NSCLC (PACIFIC-9)
Presenter: Aarthi Gopinathan- Abstract
Loading...
-
+
P1.15 - Metastatic Non-small Cell Lung Cancer - Immunotherapy
- 17:00 - 19:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
-
+
P1.15-07 - Phase II Study of Pembrolizumab and Itacitinib for First Line Treatment of Metastatic NSCLC Expressing PD-L1
Presenter: Melina Elpi Marmarelis- Abstract
Loading...
-
+
ES24 - Palliative Care Integration and QOL in Advanced Lung Cancer
- 14:45 - 15:45
- 8/08/2022
- Location: Strauss 1/2
- IASLC CME Accredited
- Type: Education Session
- Track: Palliative and Supportive Care
- Moderators:Charu Aggarwal, Karin Dieckmann
-
+
Session Moderator
15:11 - 15:23 | Presenter: Charu Aggarwal
- Abstract
Loading... -
+
Session Moderator
15:11 - 15:23 | Presenter: Karin Dieckmann
- Abstract
Loading... -
+
ES24.01 - Session Introduction
14:45 - 14:46 | Presenter: Charu Aggarwal
- Abstract
Loading... -
+
ES24.02 - Session Introduction
14:46 - 14:47 | Presenter: Karin Dieckmann
- Abstract
Loading... -
+
ES24.03 - Early Palliative Care in Advanced Non-small-Cell Lung Cancer
14:47 - 14:59 | Presenter: Jennifer Temel
- Abstract
Loading... -
+
ES24.04 - Treatment Decision-Making for Patients with Complicated Bone Metastases
14:59 - 15:11 | Presenter: Thanyanan Baisamut
- Abstract
Loading... -
+
ES24.05 - What Is the Role of Supporting Care to Improve Checkpoint Inhibitor Tolerance?
15:11 - 15:23 | Presenter: Mirjana Rajer
- Abstract
Loading... -
+
ES24.06 - The Management of Pain in Lung Cancer: Pharmacological Interventions
15:23 - 15:35 | Presenter: Marliese Alexander
- Abstract
Loading... -
+
ES24.07 - Live Q&A
15:35 - 15:45
- Abstract
Loading...
